Clinical trials are both a treatment option for all types of patients and the core way that new advances are made in MDS care. Learn more about these clinical trials.
March 24, 2023
Can Selinexor improve blood counts and bone marrow function in MDS patients?
February 08, 2023
Patients with intermediate-, high-, or very-high-risk myelodysplastic syndrome (I/H/vHR-MDS) need durable treatment options with favorable tolerability.